DecenTrialz
Study Of Tissue Iron Uptake In Iron-Deficient Patients Receiving Intravenous Iron Replacement Therapy A Prospective Observational Study

How your CV stacks up
Upload your CV to see how well it fits this job role
?%
Actively Recruiting
Age: 18 Years +
All Genders
ID: 05609318
Study of Tissue Iron Uptake in Iron-Deficient Patients Receiving Intravenous Iron Replacement Therapy
A Prospective Observational Study
Led by: University of Oxford
Updated on: 2026-05-11
12 Participants Needed
1 Research Sites
Total Duration
On this page
- AI-Summary
- Brief Title
- Who Can Participate
- AI-Screening
- Your Study Journey
- Trial Site Locations
- How is the study designed?
- Similar Trials
- Frequently Asked Questions
AI-Summary
What This Trial Is About
Researchers are studying iron-deficient patients to track how iron moves into different body tissues after an intravenous iron infusion. This observational study focuses on understanding the timing and amount of iron uptake in organs like the heart, liver, spleen, kidney, and muscles, using MRI scans and blood tests. The study is conducted by the University of Oxford and aims to improve knowledge of iron distribution after treatment. Participants receive an intravenous iron infusion Ferric carboxymaltose, Ferinject, 1000mg as part of their usual medical care. The study does not alter this treatment but follows patients over time to observe iron in tissues. Four MRI scans occur at baseline before infusion, 3 hours, 14 days, and 42 days after the infusion. Blood samples are taken at these same times to measure iron levels and markers of tissue iron damage. During the study, participants will attend visits for MRI scans and blood collection at the Oxford Centre for Clinical Magnetic Resonance Research. Researchers will measure iron uptake kinetics in various tissues and evaluate changes in blood iron markers. The study tracks participants for about six weeks after their iron infusion to gather detailed information on iron movement and effects in the body.
Reasons to use Rodeo
I’m in my final year doing Economics and I don’t know whether to apply for grad schemes now or do a masters first. What do you think?
Honest answer — it depends on where you want to end up. A lot of top grad schemes (Big 4, civil service, banking) don’t need a masters. Let’s look at the ones you’d be competitive for now, and we can decide if a masters actually adds anything.
Also worth knowing: most autumn 2026 applications are open now. Timing matters more than you think.
Start with a chat, not a search bar
Grad scheme, placement, apprenticeship? Not sure what you want yet — that's fine. Your agent talks it through with you and turns "I have no idea" into a shortlist.
Graduate Consultant — 2026 Scheme
Why you're a good match
StrongYour economics background and your summer at a regional bank line up with what PwC looks for on the consulting scheme. Applications close in four weeks.
See breakdownIt searches the market for you
Every day your agent scans the market matching roles against what actually matters to you, not just keywords on a CV.
Why you're a good match
You’ve got the grades and the economics background, and your bank internship is exactly the experience this scheme looks for. Apply soon — deadlines close within the month.
Experience fit
Your summer at the bank plus your econometrics coursework map directly to the day-one responsibilities on this scheme — client modelling, market briefings, and deal support.
Only hits
No noise. No "maybe this fits." Just roles with a clear explanation of why they're right — and where to focus when applying.
CONDITIONS
Brief Title
Imaging Intravenous Iron
Who Can Participate
Age: 18 Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Participant is willing and able to give informed consent for participation in the study.
- Aged 18 years or above.
- Have anemia (hemoglobin less than 120g/L for women and less than 130g/L for men) and/or confirmed iron deficiency (ferritin less than 100mcg/L and/or transferrin saturation less than 20%).
- Scheduled to receive intravenous iron for correction of iron deficiency.
You will not qualify if you...
- Have any MRI incompatible implants such as cardiac, neuro, ocular implants, surgical clips, aneurysm clips, or metal fragments.
- Pregnant or lactating.
- Have acute decompensated heart failure.
- Have unstable clinical status.
- Have any other medical conditions that would affect the study results as determined by the investigators.
- Have any other contraindications to MRI, including tattoos containing metal traces confirmed by the MRI operator.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
- First name *
- Last name *
- Email Address *
- Phone Number *
- +1
- Gender*
- ZIP Code *
- I agree to receive SMS messages from DecenTrialz regarding trial matching, appointment updates, participant updates, and related information. Message frequency varies. Message & data rates may apply. Reply STOP to cancel or HELP for assistance. I also agree to the Terms of Service and Privacy Policy.*
Your Study Journey
Screening
Duration: 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Diagnostic Evaluation
Duration: 42 days
Participants undergo MRI scans and blood sample collection to assess tissue iron uptake and serum iron parameters.


Get help with your application
Your very own career expert that helps elevate your application to the next level.
4 visits (baseline, 3 hours, 14 days, and 42 days post-intravenous iron infusion)
Trial Site Locations
Total: 1 location
Oxford Centre for Clinical Magnetic Resonance Research (OCMR)
Oxford, Oxfordshire, United Kingdom, OX3 9DU
Actively Recruiting
+−
Leaflet
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
- Trial of Darbepoetin Plus Slow-release Intravenous Iron to Reduce Blood Transfusions in Prematurity
- Effect of Oral Sucrosomial Iron on Exercise Capacity and Quality of Life in Chronic Heart Failure
- Feasibility and Efficacy of Intravenous Ferric Derisomaltose in Gynecologic Cancer
- Study of Tissue Iron Uptake in Iron-Deficient Patients Receiving Intravenous Iron Replacement Therapy
- A Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy and Safety of EMA401
- Point-of-care Transcutaneous Longitudinal Non-invasive Detection of Iron Deficiency in Iron Deficiency Anemia of Pregnancy
- PEPPI Study Identification of Women at Risk for Placental Dysfunction and Pre-Eclampsia
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
On this page
- AI-Summary
- Brief Title
- Who Can Participate
- AI-Screening
- Your Study Journey
- Trial Site Locations
- How is the study designed?
- Similar Trials
- Frequently Asked Questions
Sponsors
U
University of Oxford
Lead Sponsor
“It took my CV and asked me questions relevant to understanding what kind of jobs to suggest for me. Suggestions were almost perfect. Jobs were exactly what I’ve been looking for.”
Jessica, London
Skills
Location